Bulletin
Investor Alert

Bio-Techne Corp.

NAS: TECH

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 14, 2021, 4:59 p.m.

/zigman2/quotes/203973516/composite

$

401.37

Change

0.00 0.00%

Volume

Volume 2,092

Quotes are delayed by 20 min

/zigman2/quotes/203973516/composite

Today's close

$ 396.34

$ 401.37

Change

+5.03 +1.27%

Day low

Day high

$395.58

$408.57

Open

52 week low

52 week high

$228.67

$444.83

Open

Brenda Swierenga Furlow

Brenda Swierenga Furlow occupies the position of Secretary, Senior Vice President & General Counsel for Bio-Techne Corp. and Secretary at ProteinSimple, Inc. (a subsidiary of Bio-Techne Corp.). Ms. Furlow is also on the board of Tocris Cookson Ltd., Bio-Techne Ltd. and Novus Biologicals Ltd. and Member of Illinois State Bar Association and Member of State Bar of Wisconsin.

In her past career Ms. Furlow occupied the position of Associate at Alphatech Counsel SC, Secretary, Vice President & General Counsel at Promega Corp. and Secretary, Vice President & General Counsel at TomoTherapy, Inc.

She received an undergraduate degree from Calvin College and a graduate degree from The University of Chicago Law School.

Transactions

Date Shares Transaction Value
02/12/2021 3,326   Disposition at $399.12 per share. 1,327,474
02/12/2021 6,674   Disposition at $398.4 per share. 2,658,922
02/12/2021 10,000   Derivative/Non-derivative trans. at $106.59 per share. 1,065,900
11/30/2020 707   Disposition at $302.82 per share. 214,094
11/30/2020 6,783   Disposition at $302.15 per share. 2,049,484
11/30/2020 3,367   Disposition at $301.32 per share. 1,014,545
11/30/2020 938   Derivative/Non-derivative trans. at $106.59 per share. 99,981
11/30/2020 10,857   Derivative/Non-derivative trans. at $106.59 per share. 1,157,247
08/09/2020 849   Derivative/Non-derivative trans. at $265.76 per share. 225,631
08/09/2020 1,724   Derivative/Non-derivative trans. at $0 per share. 0
07/09/2020 74   Disposition at $278.84 per share. 20,635
07/09/2020 2,746   Disposition at $278.06 per share. 763,553
07/09/2020 1,954   Disposition at $277.28 per share. 541,806
07/09/2020 400   Disposition at $276.02 per share. 110,408
07/09/2020 918   Disposition at $274.8 per share. 252,267
07/09/2020 2,042   Disposition at $273.33 per share. 558,140
07/09/2020 505   Disposition at $272.48 per share. 137,603
07/09/2020 440   Disposition at $270.97 per share. 119,227
07/09/2020 9,079   Derivative/Non-derivative trans. at $108.49 per share. 984,980
05/28/2020 3,800   Disposition at $260.38 per share. 989,444
05/28/2020 2,195   Disposition at $259.72 per share. 570,086
05/28/2020 1,600   Derivative/Non-derivative trans. at $94.35 per share. 150,960
05/28/2020 5,995   Derivative/Non-derivative trans. at $108.49 per share. 650,397
12/12/2019 200   Disposition at $216.75 per share. 43,350
12/12/2019 4,147   Disposition at $216.01 per share. 895,794
12/12/2019 3,227   Disposition at $215.17 per share. 694,354
12/12/2019 426   Disposition at $214.32 per share. 91,301
12/12/2019 8,000   Derivative/Non-derivative trans. at $94.35 per share. 754,800
11/12/2019 492   Gift at $0 per share. 0
08/19/2019 745   Derivative/Non-derivative trans. at $197.57 per share. 147,190
08/19/2019 1,759   Derivative/Non-derivative trans. at $0 per share. 0
05/24/2019 5,400   Disposition at $200 per share. 1,080,000
05/24/2019 5,400   Derivative/Non-derivative trans. at $0 per share. 0
08/07/2018 438   Derivative/Non-derivative trans. at $180.14 per share. 78,902
08/07/2018 959   Derivative/Non-derivative trans. at $0 per share. 0
07/01/2017 278   Derivative/Non-derivative trans. at $117.5 per share. 32,665
07/01/2016 277   Derivative/Non-derivative trans. at $112.24 per share. 31,091

Officers and Executives

Mr. Charles R. Kummeth
President, Chief Executive Officer & Director
Mr. James T. Hippel
CFO & Principal Accounting Officer
Dr. Robert Monroe
Chief Medical Officer
Mr. Kim Kelderman
President-Diagnostics & Genomics
Ms. Brenda Swierenga Furlow
Secretary, Senior Vice President & General Counsel
Mr. Robert M. Gavin
Senior Vice President-Analytical Systems Division
Mr. Kevin S. Gould
Senior Vice President-Diagnostics Division
Mr. David Clair
Senior Director-Investor Relations
Mr. Struan Robertson
Vice President–Human Resources
Mr. Robert V. Baumgartner
Chairman
Dr. Rupert J. Vessey
Independent Director
Ms. Julie L. Bushman
Independent Director
Dr. Randolph C. Steer
Independent Director
Mr. John L. Higgins
Independent Director
Dr. Roeland Nusse
Independent Director
Dr. Alpna H. Seth
Independent Director
Dr. Joseph D. Keegan
Independent Director
Link to MarketWatch's Slice.